Suchergebnisse - "Endometrial Neoplasms mortality"

Laparoscopic surgery for endometrial cancer is oncologically safe and improves hospital stay duration: a retrospective single-center study over a 16-year period

Autoren: Anna-Christina Rambow Moritz Nikolai Peer Jansen et al.

Quelle: Arch Gynecol Obstet

Schlagwörter: Adult, Aged, 80 and over, Length of Stay/statistics, Aged, 80 and over [MeSH], Aged [MeSH], Endometrial cancer, Endometrial Neoplasms/mortality [MeSH], Hysterectomy/statistics, Germany/epidemiology [MeSH], Neoplasm Staging [MeSH], Lymph Node Excision/statistics, Female [MeSH], Lymphonodectomy, Endometrial Neoplasms/surgery [MeSH], Laparoscopy/adverse effects [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Overall survival, Retrospective Studies [MeSH], Middle Aged [MeSH], Laparoscopy/statistics, Endometrial Neoplasms/pathology [MeSH], Total laparoscopic hysterectomy, Hysterectomy/methods [MeSH], Gynecologic Oncology, Total abdominal hysterectomy, Middle Aged, Length of Stay, Hysterectomy, Endometrial Neoplasms, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Germany, Humans, Lymph Node Excision, Female, Laparoscopy, Retrospective Studies, Aged, Neoplasm Staging

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38789852
https://repository.publisso.de/resource/frl:6496763

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Autoren: Mirza, Mansoor R Chase, Dana M Slomovitz, Brian M et al.

Weitere Verfasser: Mirza, Mansoor R Chase, Dana M Slomovitz, Brian M et al.

Quelle: New England Journal of Medicine. 388:2145-2158

Schlagwörter: Immune Checkpoint Inhibitors/administration & dosage, Endometrial Neoplasms/mortality, Neoplasm Recurrence, Local/etiology, Oncologie, DNA Mismatch Repair, Carboplatin, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Paclitaxel/adverse effects, Human health sciences, Humanized, Immune Checkpoint Inhibitors, Treatments in Oncology, Endometrial Neoplasms/drug therapy, Medicine (all), General Medicine, Hematology/Oncology, 3. Good health, Neoplasm Recurrence, Local/drug therapy, Local, Oncology, Antibodies, Monoclonal, Humanized/adverse effects, Humanized/administration & dosage, Female, Microsatellite Instability, Antibodies, Monoclonal, Humanized/administration & dosage, Paclitaxel, Antibodies, Monoclonal, Humanized, Sciences de la santé humaine, Antibodies, Endometrial Neoplasms/pathology, Local/drug therapy, Carboplatin/adverse effects, Immune Checkpoint Inhibitors/adverse effects, SDG 3 - Good Health and Well-being, Double-Blind Method, Paclitaxel/administration & dosage, Humans, dostarlimab, Antineoplastic Combined Chemotherapy Protocols/adverse effects, ICTS (Institute of Clinical and Translational Sciences), Carboplatin/administration & dosage, Gynecologic Oncology, Endometrial Neoplasms, Dostarlimab, Primary Advanced, Endometrial Cancer, Neoplasm Recurrence, Obstetrics/Gynecology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Neoplasm Recurrence, Local, Endometrial Neoplasms/genetics

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36972026
https://pure.eur.nl/en/publications/55cae580-ab6c-43f9-badc-ca5cc65928d0
https://doi.org/10.1056/NEJMoa2216334
https://portal.findresearcher.sdu.dk/da/publications/7d58112a-6fc6-4d99-ac41-bc03f85a9e49
https://doi.org/10.1056/NEJMoa2216334

Treatment of endometrial cancer from 2000 to 2020 in Germany: a retrospective population based cohort study

Autoren: Papathemelis, Thomas Ortmann, Olaf Kohl, Cynthia et al.

Quelle: J Cancer Res Clin Oncol

Schlagwörter: Aged, 80 and over, Adult, ddc:610, Research, 610 Medizin, Overall survival · Outcome · Multimodal therapy · Surgery · Radiotherapy · Chemotherapy · Retrospective cohort study, Middle Aged, Prognosis, Combined Modality Therapy, Female [MeSH], Outcome, Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Overall survival, Multimodal therapy, Retrospective Studies [MeSH], Middle Aged [MeSH], Endometrial Neoplasms/mortality [MeSH], Retrospective cohort study, Germany/epidemiology [MeSH], Survival Rate [MeSH], Endometrial Neoplasms/pathology [MeSH], Endometrial Neoplasms/epidemiology [MeSH], Prognosis [MeSH], Endometrial Neoplasms/therapy [MeSH], Chemotherapy, Combined Modality Therapy [MeSH], Surgery, Radiotherapy, Registries [MeSH], Endometrial Neoplasms, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Germany, Humans, Female, Registries, Retrospective Studies, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38802682
https://repository.publisso.de/resource/frl:6492491
https://epub.uni-regensburg.de/58341/

Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: Long-term outcomes of a randomised trial: Long-term outcomes of a randomised trial

Autoren: Reijntjes, B. Suijlichem, M. van Woolderink, J.M. et al.

Quelle: Reijntjes, B, van Suijlichem, M, Woolderink, J M, Bongers, M Y, Reesink-Peters, N, Paulsen, L, van der Hurk, P J, Kraayenbrink, A A, Apperloo, M J A, Slangen, B, Schukken, T, Tummers, F H M P, van Kesteren, P J M, Huirne, J A F, Boskamp, D, Lunter, G, de Bock, G H & Mourits, M J E 2021, 'Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer : Long-term outcomes of a randomised trial', Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2021.12.019

Schlagwörter: Adult, Endometrial Neoplasms/mortality, CARCINOMA, Survival, Endometrioid/mortality, SURGERY, Laparoscopic surgery, Hysterectomy, Disease-Free Survival, Laparoscopy/methods, 03 medical and health sciences, 0302 clinical medicine, Endometrial cancer, Recurrence, Laparotomy/methods, 80 and over, Humans, Hysterectomy/methods, Adjuvant, Aged, Neoplasm Staging, Aged, 80 and over, Laparotomy, Local/epidemiology, Radiotherapy, Carcinoma, Lymphadenectomy, Middle Aged, Endometrial Neoplasms, 3. Good health, Neoplasm Recurrence, Lymph Node Excision, Female, Laparoscopy, Radiotherapy, Adjuvant, Neoplasm Grading, Neoplasm Recurrence, Local, Carcinoma, Endometrioid, RADIOTHERAPY

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34955237
https://cris.maastrichtuniversity.nl/en/publications/f73d0a07-fa34-4ae8-b8db-7daf90bc0e29
https://doi.org/10.1016/j.ygyno.2021.12.019
https://research.vumc.nl/en/publications/bf008d71-0fc3-4cc5-b1fc-1ebf4dc967b5
https://hdl.handle.net/1887/3769081

Expression of estrogen-related receptors in ovarian cancer and impact on survival

Autoren: Schüler-Toprak, Susanne Weber, Florian Skrzypczak, Maciej et al.

Quelle: J Cancer Res Clin Oncol

Schlagwörter: Ovarian Neoplasms, ERRalpha Estrogen-Related Receptor, ddc:610, 610 Medizin, Prognosis, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Endometrial Neoplasms, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Receptors, Estrogen, Cystadenocarcinoma, Serous/pathology [MeSH], Ovarian Neoplasms/mortality [MeSH], Cystadenocarcinoma, Serous/metabolism [MeSH], Adenocarcinoma, Mucinous/mortality [MeSH], Endometrial Neoplasms/mortality [MeSH], Tissue microarray, Ovarian Neoplasms/metabolism [MeSH], Estrogen-related receptors, Adenocarcinoma, Clear Cell/metabolism [MeSH], Ovarian Neoplasms/pathology [MeSH], Adenocarcinoma, Mucinous/metabolism [MeSH], Female [MeSH], Endometrial Neoplasms/metabolism [MeSH], Follow-Up Studies [MeSH], Original Article – Cancer Research, Receptors, Estrogen/metabolism [MeSH], Ovarian cancer, Humans [MeSH], Overall survival, Retrospective Studies [MeSH], Cystadenocarcinoma, Serous/mortality [MeSH], Adenocarcinoma, Clear Cell/mortality [MeSH], Survival Rate [MeSH], Endometrial Neoplasms/pathology [MeSH], Adenocarcinoma, Clear Cell/pathology [MeSH], Biomarkers, Tumor/metabolism [MeSH], Adenocarcinoma, Mucinous/pathology [MeSH], Prognosis [MeSH], Progression-free survival, Estrogen-related receptors, Ovarian cancer, Overall survival, Progression-free survival, Tissue microarray, Biomarkers, Tumor, Humans, Female, Adenocarcinoma, Clear Cell, Follow-Up Studies, Retrospective Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00432-021-03673-9.pdf
https://pubmed.ncbi.nlm.nih.gov/34089362
https://link.springer.com/content/pdf/10.1007/s00432-021-03673-9.pdf
https://www.ncbi.nlm.nih.gov/pubmed/34089362
https://epub.uni-regensburg.de/45989/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310835
https://link.springer.com/article/10.1007/s00432-021-03673-9
https://pubmed.ncbi.nlm.nih.gov/34089362/
https://link.springer.com/article/10.1007/s00432-021-03673-9
https://doi.org/10.1007/s00432-021-03673-9
https://repository.publisso.de/resource/frl:6449854
https://epub.uni-regensburg.de/45989/

Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making: Implications for shared decision making

Autoren: Post, C.C.B. Mens, J.W.M. Haverkort, M.A.D. et al.

Weitere Verfasser: Post, C.C.B. Mens, J.W.M. Haverkort, M.A.D. et al.

Quelle: Gynecologic Oncology, 161, 3, pp. 727-733

Schlagwörter: Endometrial Neoplasms/mortality, Clinician preferences, Survival, IMPACT, Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences, Radboud University Medical Center, THERAPY, VALIDATION, 03 medical and health sciences, 0302 clinical medicine, Endometrial cancer, SDG 3 - Good Health and Well-being, Adjuvants, Immunologic, QUALITY-OF-LIFE, Surveys and Questionnaires, Obstetrics and Gynaecology, Journal Article, BREAST-CANCER, SYSTEMIC TREATMENT, Humans, Aged, Netherlands, Patient preferences, Chemoradiotherapy, CHEMOTHERAPY, Middle Aged, Adjuvants, Immunologic/therapeutic use, Combined Modality Therapy, Adjuvant chemotherapy, Endometrial Neoplasms, 3. Good health, Oncology, Radiation Oncology - Radboud University Medical Center, Female, Decision Making, Shared, Decision-making

Dateibeschreibung: application/pdf

Zugangs-URL: http://www.gynecologiconcology-online.net/article/S0090825821001980/pdf
https://pubmed.ncbi.nlm.nih.gov/33712276
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/234207
https://doi.org/10.1016/j.ygyno.2021.03.004
https://www.narcis.nl/publication/RecordID/oai%3Arepository.ubn.ru.nl%3A2066%2F234207
https://www.sciencedirect.com/science/article/pii/S0090825821001980
https://europepmc.org/article/MED/33712276
https://www.ncbi.nlm.nih.gov/pubmed/33712276
https://research.rug.nl/en/publications/patients-and-clinicians-preferences-in-adjuvant-treatment-for-hig
https://www.gynecologiconcology-online.net/article/S0090-8258(21)00198-0/fulltext
https://dspace.library.uu.nl/handle/1874/445300
https://hdl.handle.net/1887/3276102
https://repository.ubn.ru.nl/handle/2066/234207
https://repository.ubn.ru.nl//bitstream/handle/2066/234207/234207.pdf

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort

Autoren: Kakkos, Athanasios Ver Eecke, C ONGARO, Sarah et al.

Quelle: European Journal of Surgical Oncology. 47:1117-1123

Schlagwörter: Adult, Endometrial Neoplasms/mortality, Hysterectomy, Sciences de la santé humaine, Obese, Endometrial Neoplasms/pathology, 03 medical and health sciences, Elderly, 0302 clinical medicine, Endometrial cancer, Belgium, Robotic Surgical Procedures, BGOG, Robot-assisted surgery, Humans, Hysterectomy/methods, Obesity, Human health sciences, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Minimally-invasive surgery, Endometrial Neoplasms/surgery, Robotic Surgical Procedures/methods, General Medicine, Reproductive medicine (gynecology, andrology, obstetrics), Length of Stay, Middle Aged, Médecine de la reproduction (Gynécologie, andrologie, obstétrique), Conversion to Open Surgery, Endometrial Neoplasms, 3. Good health, Survival Rate, Length of Stay/statistics & numerical data, Oncology, Surgery, Female, Obesity/complications

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33268212
https://www.sciencedirect.com/science/article/abs/pii/S0748798320308374
https://www.ncbi.nlm.nih.gov/pubmed/33268212
https://pubmed.ncbi.nlm.nih.gov/33268212/

Impact of socio‐economic deprivation on endometrial cancer survival in the North West of England: a prospective database analysis

Autoren: K Njoku CE Barr L Hotchkies et al.

Quelle: BJOG
Njoku, K, Barr, C, Hotchkies, L, Quille, N, Wan, L & Crosbie, E 2021, 'Impact of socioeconomic deprivation on endometrial cancer survival in the North West of England: a prospective database analysis', BJOG, vol. 128, no. 7, pp. 1215-1224. https://doi.org/10.1111/1471-0528.16618

Schlagwörter: Endometrial Neoplasms/mortality, Databases, Factual, Databases, 03 medical and health sciences, 0302 clinical medicine, Diabetes Mellitus, Humans, Obesity, Prospective Studies, England/epidemiology, Neoplasm Metastasis, 10. No inequality, Factual, Aged, Neoplasm Recurrence, Local/mortality, Manchester Cancer Research Centre, 1. No poverty, Local/mortality, Original Articles, Health Status Disparities, Obesity/epidemiology, Middle Aged, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre, Endometrial Neoplasms, 3. Good health, Neoplasm Recurrence, England, Social Class, Socioeconomic Factors, Diabetes Mellitus/epidemiology, Female, Neoplasm Recurrence, Local

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1471-0528.16618
https://pubmed.ncbi.nlm.nih.gov/33289967
https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.16618
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248174
https://www.research.manchester.ac.uk/portal/en/publications/impact-of-socioeconomic-deprivation-on-endometrial-cancer-survival-in-the-north-west-of-england-a-prospective-database-analysis(4a026d38-ce51-4673-8e9c-9e4506612abe).html
https://pubmed.ncbi.nlm.nih.gov/33289967/

Klinische Implikationen der PORTEC-3-Studie zur Behandlung des Hochrisikoendometriumkarzinoms

Autoren: Waltar, Till Marnitz, Simone

Quelle: Strahlentherapie und Onkologie. 196:410-413

Schlagwörter: 03 medical and health sciences, 0302 clinical medicine, Chemoradiotherapy, Adjuvant [MeSH], Paclitaxel/administration, Female [MeSH], Area Under Curve [MeSH], Disease Progression [MeSH], Hysterectomy [MeSH], Cisplatin/administration, Brachytherapy [MeSH], Humans [MeSH], Literatur Kommentiert, Risk Factors [MeSH], Endometrial Neoplasms/mortality [MeSH], Oncology, Lymph Node Excision [MeSH], Neoplasm Staging [MeSH], Survival Rate [MeSH], Chemotherapy, Adjuvant [MeSH], Endometrial Neoplasms/pathology [MeSH], Neoplasm Recurrence, Local/radiotherapy [MeSH], Endometrial Neoplasms/radiotherapy [MeSH], Combined Modality Therapy [MeSH], Radiotherapy, Neoplasm Recurrence, Local/mortality [MeSH], 3. Good health

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00066-020-01592-1.pdf
https://pubmed.ncbi.nlm.nih.gov/32072198/
https://www.ncbi.nlm.nih.gov/pubmed/32072198
https://link.springer.com/content/pdf/10.1007%2Fs00066-020-01592-1.pdf
https://link.springer.com/article/10.1007/s00066-020-01592-1
https://paperity.org/p/233545483/klinische-implikationen-der-portec-3-studie-zur-behandlung-des
https://repository.publisso.de/resource/frl:6441856

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial: final results of an international, open-label, multicentre, randomised, phase 3 trial

Autoren: de Boer S.M. Powell M.E. Mileshkin L. et al.

Quelle: Lancet Oncol
Lancet Oncology, 19, 3, pp. 295-309
PORTEC study group 2018, 'Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3) : final results of an international, open-label, multicentre, randomised, phase 3 trial', The Lancet Oncology, vol. 19, no. 3, pp. 295-309. https://doi.org/10.1016/S1470-2045(18)30079-2

Schlagwörter: 0301 basic medicine, Time Factors, PROGNOSIS, Endometrial Neoplasms/mortality, Endometrioid/mortality, GYNECOLOGIC-ONCOLOGY-GROUP, Carboplatin, Aged, Antineoplastic Combined Chemotherapy Protocols, Australia, Canada, Carcinoma, Endometrioid, Cisplatin, Endometrial Neoplasms, Europe, Female, Humans, Lymph Node Excision, Middle Aged, Neoplasm Grading, Neoplasm Staging, New Zealand, Paclitaxel, Radiotherapy, Adjuvant, Risk Factors, Treatment Outcome, Chemoradiotherapy, Adjuvant, Dose Fractionation, Radiation, Gynecologic Surgical Procedures, CARCINOMA PATIENTS, 0302 clinical medicine, QUALITY-OF-LIFE, Adjuvant/adverse effects, Medical Oncology - Radboud University Medical Center, Dose Fractionation, Adjuvant, Radiation, Chemoradiotherapy, CHEMOTHERAPY, 3. Good health, STAGE-I, Radiation Oncology - Radboud University Medical Center, CLINICAL-TRIALS, Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences, Radboud University Medical Center, Article, 03 medical and health sciences, Paclitaxel/administration & dosage, RADIATION-THERAPY, RECURRENCE, III TRIAL, Radiotherapy, Gynecologic Surgical Procedures/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Carcinoma, Carboplatin/administration & dosage, Cisplatin/administration & dosage

Dateibeschreibung: application/pdf

Zugangs-URL: http://www.thelancet.com/article/S1470204518300792/pdf
https://pubmed.ncbi.nlm.nih.gov/29449189
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/193607
https://doi.org/10.1016/S1470-2045(18)30079-2
https://research.manchester.ac.uk/en/publications/ed994f55-ad3b-42a4-b9e5-00c6676b30e6
https://doi.org/10.1016/S1470-2045(18)30079-2
https://research.rug.nl/en/publications/1db1c1f6-290f-44bf-9fe8-62e361300032
https://hdl.handle.net/11370/1db1c1f6-290f-44bf-9fe8-62e361300032
https://doi.org/10.1016/S1470-2045(18)30079-2
https://www.sciencedirect.com/science/article/abs/pii/S1470204518300792
https://minerva-access.unimelb.edu.au/handle/11343/255809
https://discovery.ucl.ac.uk/id/eprint/10044765/
http://dspace.library.uu.nl/handle/1874/363891
https://www.rug.nl/research/portal/en/publications/adjuvant-chemoradiotherapy-versus-radiotherapy-alone-for-women-with-highrisk-endometrial-cancer-portec3(bd4c3f0a-9e12-4301-a136-9ca683e3909a).html
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840256
https://hdl.handle.net/1887/74981
https://repository.ubn.ru.nl//bitstream/handle/2066/193607/193607.pdf
https://hdl.handle.net/2066/193607
https://discovery-pp.ucl.ac.uk/id/eprint/10044765/

The impact of the survivorship care plan on health care use: 2-year follow-up results of the ROGY care trial: 2-year follow-up results of the rogy care trial

Autoren: Roy F.P.M. Kruitwagen Lonneke V. van de Poll-Franse Nicole P. M. Ezendam et al.

Quelle: Journal of Cancer Survivorship, 12, 1, pp. 18-27
Jeppesen, M M, Ezendam, N P M, Pijnenborg, J M A, Caroline Vos, M, Boll, D, Kruitwagen, R F P M, Jensen, P T & van de Poll-Franse, L V 2018, ' The impact of the survivorship care plan on health care use : 2-year follow-up results of the ROGY care trial ', Journal of Cancer Survivorship, vol. 12, no. 1, pp. 18–27 . https://doi.org/10.1007/s11764-017-0639-7

Schlagwörter: Adult, Endometrial Neoplasms/mortality, Cancer survivorship, Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences, Radboud University Medical Center, Endometrial carcinoma, HOSPITAL ANXIETY, Survivorship, CLINICAL-TRIAL, COLORECTAL-CANCER, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Delivery of Health Care/standards, BREAST-CANCER SURVIVORS, Surveys and Questionnaires, Journal Article, Humans, Aged, RANDOMIZED CONTROLLED-TRIAL, SERVICES, Middle Aged, ONCOLOGY, Endometrial Neoplasms, 3. Good health, DEPRESSION SCALE, Gynecologic oncology, SCP, Female, Delivery of Health Care, Follow-Up Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/28875470
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/184067
https://research.tilburguniversity.edu/en/publications/7429f25b-8158-448d-8d1d-a5e94f6bb226
https://doi.org/10.1007/s11764-017-0639-7
https://pubmed.ncbi.nlm.nih.gov/28875470/
https://research.tilburguniversity.edu/en/publications/the-impact-of-the-survivorship-care-plan-on-health-care-use-2-yea
https://www.ncbi.nlm.nih.gov/pubmed/28875470
https://repository.ubn.ru.nl/handle/2066/184067
https://link.springer.com/article/10.1007/s11764-017-0639-7
https://www.narcis.nl/publication/RecordID/oai%3Arepository.ubn.ru.nl%3A2066%2F184067
https://hdl.handle.net/2066/184067
https://repository.ubn.ru.nl//bitstream/handle/2066/184067/184067.pdf
https://portal.findresearcher.sdu.dk/da/publications/7988af49-bb70-4e5f-8b8f-034fdf55c181

A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study

Autoren: Hanbyoul Cho Byung-Ho Nam Seok Mo Kim et al.

Weitere Verfasser: Hanbyoul Cho Byung-Ho Nam Seok Mo Kim et al.

Quelle: International Journal of Radiation Oncology*Biology*Physics. 90:140-146

Schlagwörter: Radiation-Sensitizing Agents/therapeutic use, Adult, 0301 basic medicine, Radiation-Sensitizing Agents, Endometrial Neoplasms/mortality, Paclitaxel, Endometrioid/mortality, Chemoradiotherapy/methods, Endometrioid/secondary, Phytogenic/therapeutic use, Antineoplastic Agents, Chemoradiotherapy/adverse effects, Endometrial Neoplasms/pathology, Disease-Free Survival, Phytogenic/adverse effects, 03 medical and health sciences, 0302 clinical medicine, Endometrial Neoplasms/therapy, Paclitaxel/therapeutic use, Republic of Korea, Paclitaxel/adverse effects, Confidence Intervals, Humans, Radiation-Sensitizing Agents/adverse effects, Prospective Studies, Dose Fractionation, Aged, Postoperative Care, 2. Zero hunger, Endometrioid/therapy, Carcinoma, Local/mortality, Chemoradiotherapy, Middle Aged, Antineoplastic Agents, Phytogenic, Survival Analysis, Endometrial Neoplasms, 3. Good health, Endometrioid/pathology, Neoplasm Recurrence, Female, Dose Fractionation, Radiation, Neoplasm Recurrence, Local, Carcinoma, Endometrioid, Local/pathology

Dateibeschreibung: 140~146

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/25015202
https://yonsei.pure.elsevier.com/en/publications/a-phase-2-trial-of-radiation-therapy-with-concurrent-paclitaxel-c
https://www.ncbi.nlm.nih.gov/pubmed/25015202
http://repository.ajou.ac.kr/bitstream/201003/12792/1/25015202.pdf
https://europepmc.org/article/MED/25015202
https://www.sciencedirect.com/science/article/pii/S0360301614006245
https://pubmed.ncbi.nlm.nih.gov/25015202/

Effects of Uterine Manipulation on Surgical Outcomes in Laparoscopic Management of Endometrial Cancer

Autoren: Jae Hoon Kim Sang Wun Kim Sunghoon Kim et al.

Weitere Verfasser: Jae Hoon Kim Sang Wun Kim Sunghoon Kim et al.

Quelle: International Journal of Gynecological Cancer. 23:372-379

Schlagwörter: Endometrioid/pathology, Endometrial Neoplasms/mortality, Endometrioid/mortality, Lymphovascular space invasion, Endometrial Neoplasms/surgery, Laparoscopy, Endometrioid/surgery, 03 medical and health sciences, 0302 clinical medicine, Endometrial cancer, Humans, Neoplasm Invasiveness, Aged, Neoplasm Staging, Endometrial Neoplasms/diagnosis, Carcinoma, Uterus, Endometrioid/diagnosis, Middle Aged, Prognosis, Survival Analysis, Endometrial Neoplasms, 3. Good health, Treatment Outcome, Uterine manipulator, Endometrial Neoplasms/pathology, Female, Neoplasm Staging/methods, Cytology, Carcinoma, Endometrioid, Uterus/surgery

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/23266650
https://europepmc.org/article/MED/23266650
https://ir.ymlib.yonsei.ac.kr/handle/22282913/86639
https://yonsei.pure.elsevier.com/en/publications/effects-of-uterine-manipulation-on-surgical-outcomes-in-laparosco
https://mdanderson.elsevierpure.com/en/publications/effects-of-uterine-manipulation-on-surgical-outcomes-in-laparosco
https://pubmed.ncbi.nlm.nih.gov/23266650/
https://ijgc.bmj.com/content/23/2/372

Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy

Autoren: Hanbyoul Cho Young Tae Kim Jae Hoon Kim et al.

Weitere Verfasser: Hanbyoul Cho Young Tae Kim Jae Hoon Kim et al.

Quelle: Acta Obstetricia et Gynecologica Scandinavica. 89:175-181

Schlagwörter: Adult, Endometrial Neoplasms/mortality, Preoperative Care, Myometrium/pathology, Sensitivity and Specificity, 03 medical and health sciences, 0302 clinical medicine, Endometrial cancer, 80 and over, Humans, Neoplasm Invasiveness, Aged, Retrospective Studies, Aged, 80 and over, Middle Aged, surgical staging, Prognosis, Magnetic Resonance Imaging, Endometrial Neoplasms, 3. Good health, Lymphatic Metastasis, lymphadenectomy, Lymph Node Excision, Lymph Nodes/pathology, Myometrium, Endometrial Neoplasms/pathology, Female, Lymph Nodes, preoperative tests

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/19943822
http://onlinelibrary.wiley.com/doi/10.3109/00016340903418785/abstract
https://obgyn.onlinelibrary.wiley.com/doi/10.3109/00016340903418785
https://www.ncbi.nlm.nih.gov/pubmed/19943822
https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.3109/00016340903418785
https://yonsei.pure.elsevier.com/en/publications/accuracy-of-preoperative-tests-in-clinical-stage-i-endometrial-ca

The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas

Autoren: Olcha, Piotr Cybulski, Marek Skomra, Danuta et al.

Quelle: International Journal of Gynecological Cancer. 20(6):993-999

Schlagwörter: Adult, Tumor suppressor protein p53 - metabolism, Kaplan-Meier estimate, Biopsy, Neoplasm metastasis, Tumor suppressor protein p53 - genetics, Carcinoma - mortality, Signal transduction, Tumor suppressor protein p14ARF - metabolism, Carcinoma - secondary, Neoplasm invasiveness - genetics, needle, 80 and over, Humans, Carcinoma - metabolism, nonparametric, Tumor suppressor protein p14ARF - geneti, Middle aged, Aged, Risk assessment, Gene expression regulation, tumor - genetics, Endometrial neoplasms - metabolism, Statistics, tumor - metabolism, Endometrial neoplasms - mortality, Neoplasm invasiveness - pathology, Survival analysis, Prognosis, Chi-square distribution, Immunohistochemistry, neoplastic, Retrospective studies, Neoplasm staging, Cohort studies, Female, Biomarkers, Endometrial neoplasms - pathology

Diagnostic and Prognostic Impact of Osteopontin Expression in Endometrial Cancer

Autoren: Jae Hoon Kim Hanbyoul Cho Eun Suk Kang et al.

Weitere Verfasser: Jae Hoon Kim Hanbyoul Cho Eun Suk Kang et al.

Quelle: Cancer Investigation. 27:313-323

Schlagwörter: Adult, 0301 basic medicine, Endometrial Neoplasms/mortality, Tumor/blood, Polymerase Chain Reaction, Osteopontin/genetics, 03 medical and health sciences, Osteopontin (OPN), 0302 clinical medicine, Osteopontin/analysis, Biomarkers, Tumor, Humans, CA-125 Antigen/blood, Aged, Proportional Hazards Models, Osteopontin/blood, diagnostic marker, Middle Aged, Prognosis, Immunohistochemistry, Endometrial Neoplasms, 3. Good health, CA-125 Antigen, endometrial cancer, Endometrial Neoplasms/diagnosis, Female, Osteopontin, Biomarkers, prognostic marker

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/19194826
https://www.tandfonline.com/doi/abs/10.1080/07357900802375738
https://yonsei.pure.elsevier.com/en/publications/diagnostic-and-prognostic-impact-of-osteopontin-expression-in-end
https://www.ncbi.nlm.nih.gov/pubmed/19194826
https://europepmc.org/article/MED/19194826

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Autoren: de Boer, Stephanie M. Powell, Melanie E. Mileshkin, Linda et al.

Weitere Verfasser: de Boer, Stephanie M. Powell, Melanie E. Mileshkin, Linda et al.

Schlagwörter: Canada, Time Factors, Endometrial Neoplasms/mortality, Clinical Trial, Phase III, Risk Factors, Paclitaxel/administration & dosage, Journal Article, Humans, Comparative Study, Aged, Neoplasm Staging, Gynecologic Surgical Procedures/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Research Support, Non-U.S. Gov't, Australia, Carboplatin/administration & dosage, Chemoradiotherapy, Adjuvant/adverse effects, Middle Aged, 3. Good health, Europe, Multicenter Study, Treatment Outcome, Oncology, Randomized Controlled Trial, Carcinoma, Endometrioid/mortality, Lymph Node Excision, Female, Radiotherapy, Adjuvant, Dose Fractionation, Radiation, Neoplasm Grading, Cisplatin/administration & dosage, New Zealand

Dateibeschreibung: image/pdf

Zugangs-URL: https://dspace.library.uu.nl/handle/1874/363891

Clinicopathologic and Biological Parameters Predicting the Prognosis in Endometrial Cancer

Weitere Verfasser: Jae Wook Kim Sung Hoon Kim Young Tae Kim et al.

Quelle: T200206869.pdf

Schlagwörter: Adult, Aged, Apoptosis, Endometrial Neoplasms/mortality, Endometrial Neoplasms/pathology, Female, Genes, Tumor Suppressor, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Oncogenes, Prognosis, Endometrial cancer, clinicopathologic parameters, biological parameters

Dateibeschreibung: 769~778

Relation: YONSEI MEDICAL JOURNAL; J02813; https://ir.ymlib.yonsei.ac.kr/handle/22282913/144052; T200206869; 55550

Verfügbarkeit: https://ir.ymlib.yonsei.ac.kr/handle/22282913/144052
https://doi.org/10.3349/ymj.2002.43.6.769

The prognostic significance of progesterone receptor level in endometrial cancer / Den prognostiske betydning af progesteronreceptorindhold ved endometriecancer

Autoren: Nyholm, H C Jarle Christensen, I Lynge Nielsen, A

Quelle: Ugeskrift for Laeger. 159(5):601

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer

Autoren: Piotr Bernaczyk Bozena Dobrzycka Magdalena Garbowicz et al.

Quelle: Folia Histochemica et Cytobiologica, Vol 48, Iss 4, Pp 678-681 (2011)
Folia Histochemica et Cytobiologica, Vol 48, Iss 4, Pp 678-681 (2010)

Schlagwörter: Intracellular signaling peptides and proteins - metabolism, 0301 basic medicine, 0303 health sciences, QH573-671, Intracellular Signaling Peptides and Proteins, Endometrial neoplasms - mortality, endometrioid endometrial cancer, Endometrial neoplasms - diagnosis, Apoptosis, Middle Aged, Prognosis, Immunohistochemistry, Endometrial Neoplasms, Mitochondrial Proteins, 03 medical and health sciences, Mitochondrial proteins - metabolism, smac/DIABLO, Humans, Female, prognosis, Middle aged, Cytology, Apoptosis Regulatory Proteins, Endometrial neoplasms - pathology, Aged

Zugangs-URL: https://journals.viamedica.pl/folia_histochemica_cytobiologica/article/download/4181/3436
https://pubmed.ncbi.nlm.nih.gov/21478115
https://doaj.org/article/5421d7156f224e14be8d963324676972
https://doaj.org/article/4ee991dffa7844cca2de06d4e44db861
https://journals.viamedica.pl/folia_histochemica_cytobiologica/article/download/4181/3436
https://journals.viamedica.pl/folia_histochemica_cytobiologica/article/view/4181
https://www.ncbi.nlm.nih.gov/pubmed/21478115
http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.dl-catalog-c483ef57-561b-4d41-9242-4f5fe95edcce
http://czasopisma.viamedica.pl/fhc/article/view/4181